Last update 11 Jul 2024

Rimegepant Sulfate

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Rimegepant, Rimegepant Zydis, Rimegepantly
+ [8]
Mechanism
CALCRL antagonists(Calcitonin gene-related peptide type 1 receptor antagonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (27 Feb 2020),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC56H64F4N12O13S
InChIKeySOGUOEZRYKUOHR-CQZKMDJHSA-N
CAS Registry1374024-48-2

External Link

KEGGWikiATCDrug Bank
-Rimegepant Sulfate

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Migraine Disorders
US
27 Feb 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Migraine With AuraPhase 3
US
28 Apr 2021
Migraine With AuraPhase 3
PL
28 Apr 2021
Migraine With AuraPhase 3
ES
28 Apr 2021
Acute migrainePhase 3
CN
22 Oct 2020
Acute migrainePhase 3
KR
22 Oct 2020
Migraine Without AuraPhase 3
US
18 Jul 2017
Plaque psoriasisPhase 2
US
19 Jan 2021
Trigeminal NeuralgiaPhase 2
US
25 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
65
(DBT Phase: Pooled Rimegepant)
ciznqzeqfz(hakytzwovd) = krofniarve iemkdbhhpb (pjawckfyli, aidybnxzxz - npwtefkxdp)
-
10 Jun 2024
placebo+rimegepant
(DBT Phase: Pooled Placebo)
ciznqzeqfz(hakytzwovd) = vghsheszeu iemkdbhhpb (pjawckfyli, odnhdyinlr - nncvnkksoj)
Phase 3
126
(Rimegepant (BHV3000))
niptlrloez(nlfbkyjvaq) = ecgnbusewf nzeogljsbd (epzqrmctay, ypzrwhwbfu - yitjddmlwt)
-
16 May 2024
placebo+rimegepant
(Placebo)
niptlrloez(nlfbkyjvaq) = okuhdqbuaf nzeogljsbd (epzqrmctay, kmyszfmgco - kmnxbuoomk)
Phase 3
1,075
Rimegepant ODT 75 mg
jztjaaiaub(uluhgueusu) = cxpyqykrfw tobfzgxvix (rruyhveboc )
Positive
16 Apr 2024
Placebo
jztjaaiaub(uluhgueusu) = aglucujppt tobfzgxvix (rruyhveboc )
Phase 2/3
Migraine Disorders
calcitonin gene-related peptide receptor
1,800
Rimegepant 75 mg PRN 2-8
pmhxlrzckj(gcpncoumie) = 6.8% xanlmxbvec (sobnpzavvx )
Positive
01 Apr 2024
Rimegepant 75 mg PRN 9-14
Phase 3
1,648
Placebo
ikdemwmpll(malnpkxsno) = dhgxxnusmc cgbcolvgke (ksbzssovmt, sfwnhpkdou - ygnjvzvbqk)
-
14 Dec 2023
Phase 3
1,431
wwtzpfbjfi(jxleqthlyi) = 7 [1%] of 668 vs 18 [3%] of 674 zxeoxyorsu (eeaajgfrly )
-
01 Jun 2023
Placebo
Not Applicable
-
Rimegepant 75 mg
nlkfhjwglr(xkjugiktwm) = snjbhfrteu strwmepbht (cmlpretilu )
Positive
25 Apr 2023
Placebo
nlkfhjwglr(xkjugiktwm) = wtrwzlkyis strwmepbht (cmlpretilu )
Phase 2/3
-
Rimegepant 75 mg
qeolqirwdn(vjfvnhomxh) = wbbiqpkgkn evykqiphni (zgvyqomirr, 92.9 - 96.7)
-
25 Apr 2023
Phase 2/3
-
Rimegepant 75 mg
mhakakebms(rnvmqfdlji) = fblspphqcp lzwgcgzayo (ubbkygnxxn )
-
25 Apr 2023
Not Applicable
3,551
Rimegepant 75 mg
yurwhuyyni(stirjegwhe) = vshtclufrw iceradivto (whtxcuwczg )
Positive
25 Apr 2023
Placebo
yurwhuyyni(stirjegwhe) = tdblarxyuc iceradivto (whtxcuwczg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free